LTRN

NASDAQ · Biotechnology

Lantern Pharma Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$2.64

+0.08 (+3.13%)

As of Feb 8, 2:22 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +884.1% upside

Low Target $20.93

Average Target $25.98

High Target $39.39

Current Price $2.64

Current
$2.64

Target
$25.98

$20.93 $25.98 avg $39.39

Scenario Analysis

Bear Case

$20.93

692.8%

Low target

Base Case

$25.98

+884.1%

Avg target

Bull Case

$39.39

+1,392.0%

High target

Risk/Reward

2.0x

Favorable

Price in Context

52-Week High

$31.38

-91.6% from high

52-Week Low

$14.16

+-81.4% from low

Target vs 52W High

$25.98

-17.2% vs high

Next Earnings Report

Mar 5, 2026 · After Market Close

17d

until earnings

EPS Est: $-0.47

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%